Search research articles
Contact Us
Filters
Showing results (131-140 of 149) with videos related to
Page
of 15
Sort By:
The American Journal of Physiology
|
December 1, 1993
Sex difference in the antidiuretic activity of vasopressin in the rat
Y X Wang, R M Edwards, P Nambi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
March 11, 2000
Apoptosis in polycystic kidney disease: involvement of caspases
S M Ali, V Y Wong, K Kikly, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 11, 1992
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism
E H Ohlstein, M Gellai, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs
D P Brooks, P D dePalma, M Gellai, et al.
The American Journal of Physiology
|
September 1, 1987
Adrenergic mediation of vasopressin secretion in newborn pigs
C W Leffler, D W Busija, L Share, et al.
Phytochemistry
|
July 1, 1993
A diterpene epoxide from the marine brown alga Dictyota sp.: possible vasopressin V1 receptor antagonist
A D Patil, D Berry, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1993
Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis
D P Brooks, G Giardina, M Gellai, et al.
Journal of the American Society of Nephrology : JASN
|
January 24, 1998
The age-related increase in renal clusterin mRNA is accelerated in obese Zucker rats
N J Laping, B A Olson, J R Day, et al.
European Journal of Pharmacology
|
January 24, 1989
Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements
D P Brooks, P F Koster, C R Albrightson, et al.
Journal of Cardiovascular Pharmacology
|
May 22, 1998
Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083
S A Douglas, P Nambi, M Gellai, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 149) with videos related to
Sort By:
Page
of 15
The American Journal of Physiology
|
December 1, 1993
Sex difference in the antidiuretic activity of vasopressin in the rat
Y X Wang, R M Edwards, P Nambi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
March 11, 2000
Apoptosis in polycystic kidney disease: involvement of caspases
S M Ali, V Y Wong, K Kikly, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 11, 1992
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism
E H Ohlstein, M Gellai, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs
D P Brooks, P D dePalma, M Gellai, et al.
The American Journal of Physiology
|
September 1, 1987
Adrenergic mediation of vasopressin secretion in newborn pigs
C W Leffler, D W Busija, L Share, et al.
Phytochemistry
|
July 1, 1993
A diterpene epoxide from the marine brown alga Dictyota sp.: possible vasopressin V1 receptor antagonist
A D Patil, D Berry, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1993
Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis
D P Brooks, G Giardina, M Gellai, et al.
Journal of the American Society of Nephrology : JASN
|
January 24, 1998
The age-related increase in renal clusterin mRNA is accelerated in obese Zucker rats
N J Laping, B A Olson, J R Day, et al.
European Journal of Pharmacology
|
January 24, 1989
Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements
D P Brooks, P F Koster, C R Albrightson, et al.
Journal of Cardiovascular Pharmacology
|
May 22, 1998
Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083
S A Douglas, P Nambi, M Gellai, et al.
Page
of 15